Brookfield Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-180,000	Closed	-$18.5M	–	582
2023 Q2	$18.5M	Sell	180,000 -20,000	-10%	-$2.11M	0.07%	99
2023 Q1	$21.8M	Buy	200,000 +117,500	+142%	+$13M	0.09%	98
2022 Q4	$9.39M	Sell	82,500 -3,473	-4%	-$288K	0.04%	159
2022 Q3	$5.32M	Buy	85,973 +21,283	+33%	+$1.49M	0.02%	268
2022 Q2	$5.16M	Sell	64,690 -51,494	-44%	-$4.88M	0.02%	249
2022 Q1	$12.2M	Buy	116,184 +36,075	+45%	+$3.52M	0.05%	132
2021 Q4	$8.63M	Buy	80,109 +11,331	+16%	+$1.24M	0.03%	142
2021 Q3	$7.53M	Buy	+68,778	New	+$7.14M	0.03%	170